Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Detalles Bibliográficos
Autores principales: Blum, Vinicius Fontanesi, Cimerman, Sérgio, Hunter, James R, Tierno, Paulo, Lacerda, Acioly, Soeiro, Alexandre, Cardoso, Florentino, Bellei, Nancy Cristina, Maricato, Juliana, Mantovani, Nathalia, Vassao, Marcella, Dias, Danilo, Galinskas, Juliana, Janini, Luis Mário Ramos, Santos-Oliveira, Joanna Reis, Da-Cruz, Alda Maria, Diaz, Ricardo Sobhie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/
https://www.ncbi.nlm.nih.gov/pubmed/34805808
http://dx.doi.org/10.1016/j.eclinm.2021.101203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/
https://www.ncbi.nlm.nih.gov/pubmed/34805808
http://dx.doi.org/10.1016/j.eclinm.2021.101203

Ejemplares similares